Capricor Therapeutics, Inc. ( CAPR ) is a biotechnology company that advances two platforms. The first one is its cardiosphere-derived cell therapy called Deramiocel, and the second is its StealthX exosome engineering. Still, I consider its flagship candidate is Deramiocel, which has secured the FDA’sMy name is Myriam Hernandez Alvarez. I received the Electronics and Telecommunication Engineering degree from the Escuela Politecnica Nacional, Quito, Ecuador, the M.Sc. degree in computer science from Ohio Uni ...